Journal
GASTROENTEROLOGY CLINICS OF NORTH AMERICA
Volume 47, Issue 2, Pages 267-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.gtc.2018.01.002
Keywords
Liver transplantation; Liver cancer; Neoadjuvant radiotherapy; Hilar cholangiocarcinoma; Intrahepatic cholangiocarcinoma
Categories
Ask authors/readers for more resources
Liver transplant (LT) for perihilar cholangiocarcinoma (CCA) offers an opportunity for survival among patients with early-stage but anatomically unresectable disease. The 5-year survival rate after LT is 65% to 70%, higher among patients with primary sclerosing cholangitis, who are often diagnosed earlier, and lower among patients with de novo CCA. The results of LT for hilar CCA, along with recent limited data suggesting favorable survival among patients with very early intrahepatic CCA (ICC), have reignited interest in the subject. This article discusses LT following neoadjuvant therapy for CCA and the early data on LT alone for ICC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available